TEGLICAR

SynDRA canonical compound SYN0024202 — structure-anchored drug synonym record

Clinical phase	Phase 2
Primary target(s)	CPT1A
Mechanism of action	carnitine palmitoyltransferase inhibitor
Indication	diabetes mellitus
Disease area	endocrinology

All known targets

CPT1A
CRAT

Mechanisms of action (all sources)

carnitine palmitoyltransferase inhibitor
CRAT INHIBITOR

Cross-references

PubChem CID: 9843897
ChEMBL: CHEMBL1231506
DrugBank: DB20358
ChEBI: 234386
PDB: BUI
TTD: D01FCK

Synonyms

Reversible palmitoyltransferase inhibitor
ST-1326
Teglicar [INN]
4-trimethylammonio-TDCAB
UNII-8V3VQ6HMII
8V3VQ6HMII
compound 17 [Giannessi et al., 2003]
compound 17 (Giannessi et al., 2003)
teglicarum
RefChem:187713
st1326
(R)-3-(3-Tetradecylureido)-4-(trimethylammonio)butanoate
orb1708390
SCHEMBL3685373
GTPL12976
BDBM50122839
EX-A11229
AKOS027323786
BP-43094
HY-16482
MS-26779
CS-0006357
G13312
T13113
ST1326; (R)-N-TETRADECYLCARBAMOYL-AMINOCARNITINE
Teglicar?
CHEBI:234386
(R)-N-(tetradecylcarbamoyl)aminocarnitine
Carnitine Palmitoyltransferase 1 Inhibitor

Look up TEGLICAR in the interactive SynDRA portal →